Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRVS |
---|---|---|
09:32 ET | 40600 | 2.22 |
09:34 ET | 400 | 2.18 |
09:36 ET | 300 | 2.19 |
09:41 ET | 100 | 2.19 |
09:43 ET | 100 | 2.125 |
09:45 ET | 1958 | 2.1 |
09:50 ET | 2045 | 2.0901 |
09:52 ET | 100 | 2.11 |
09:54 ET | 100 | 2.14 |
10:01 ET | 1100 | 2.12 |
10:10 ET | 100 | 2.12 |
10:12 ET | 1700 | 2.14 |
10:14 ET | 1100 | 2.1294 |
10:15 ET | 2000 | 2.13 |
10:19 ET | 200 | 2.135 |
10:21 ET | 100 | 2.15 |
10:24 ET | 200 | 2.148 |
10:26 ET | 2924 | 2.1499 |
10:28 ET | 1700 | 2.1499 |
10:30 ET | 2633 | 2.14 |
10:32 ET | 918 | 2.13 |
10:35 ET | 100 | 2.14 |
10:39 ET | 800 | 2.14 |
10:48 ET | 148 | 2.14 |
10:51 ET | 100 | 2.14 |
10:57 ET | 2536 | 2.14 |
11:02 ET | 100 | 2.15 |
11:04 ET | 2000 | 2.1493 |
11:06 ET | 2000 | 2.1497 |
11:08 ET | 400 | 2.15 |
11:09 ET | 200 | 2.155 |
11:22 ET | 100 | 2.17 |
11:26 ET | 13964 | 2.09 |
11:29 ET | 600 | 2.13 |
11:31 ET | 200 | 2.13 |
11:33 ET | 100 | 2.13 |
11:49 ET | 400 | 2.09 |
11:56 ET | 100 | 2.085 |
12:00 ET | 100 | 2.085 |
12:20 ET | 400 | 2.07 |
12:23 ET | 600 | 2.07 |
12:43 ET | 383 | 2.085 |
12:48 ET | 700 | 2.08 |
12:50 ET | 1000 | 2.1 |
12:52 ET | 500 | 2.1 |
12:56 ET | 500 | 2.1101 |
12:57 ET | 300 | 2.11 |
01:06 ET | 100 | 2.11 |
01:12 ET | 100 | 2.12 |
01:17 ET | 100 | 2.11 |
01:35 ET | 225 | 2.11 |
01:37 ET | 100 | 2.1 |
01:39 ET | 900 | 2.095 |
02:00 ET | 100 | 2.08 |
02:02 ET | 376 | 2.06 |
02:11 ET | 200 | 2.09 |
02:13 ET | 300 | 2.075 |
02:31 ET | 300 | 2.065 |
02:33 ET | 2576 | 2.08 |
02:42 ET | 300 | 2.1 |
02:45 ET | 100 | 2.1 |
02:49 ET | 2439 | 2.1 |
02:51 ET | 306 | 2.12 |
02:54 ET | 333 | 2.14 |
02:56 ET | 100 | 2.13 |
02:58 ET | 6000 | 2.0906 |
03:00 ET | 200 | 2.115 |
03:02 ET | 400 | 2.127 |
03:03 ET | 500 | 2.14 |
03:05 ET | 100 | 2.14 |
03:09 ET | 300 | 2.14 |
03:16 ET | 100 | 2.15 |
03:20 ET | 100 | 2.15 |
03:21 ET | 1600 | 2.15 |
03:23 ET | 1200 | 2.1545 |
03:27 ET | 1300 | 2.1799 |
03:30 ET | 7012 | 2.11 |
03:32 ET | 330 | 2.135 |
03:34 ET | 600 | 2.15 |
03:36 ET | 700 | 2.145 |
03:38 ET | 100 | 2.145 |
03:39 ET | 1200 | 2.1301 |
03:41 ET | 500 | 2.12 |
03:43 ET | 1500 | 2.115 |
03:45 ET | 932 | 2.1019 |
03:48 ET | 800 | 2.13 |
03:50 ET | 100 | 2.13 |
03:52 ET | 1500 | 2.13 |
03:57 ET | 200 | 2.11 |
03:59 ET | 4177 | 2.07 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Corvus Pharmaceuticals Inc | 129.5M | -4.0x | --- |
aTyr Pharma Inc | 131.1M | -2.0x | --- |
Cardiff Oncology Inc | 131.9M | -3.1x | --- |
RAPT Therapeutics Inc | 123.5M | -1.1x | --- |
Cytodyn Inc | 136.2M | -2.5x | --- |
Nuvectis Pharma Inc | 122.1M | -4.9x | --- |
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of ITK inhibition as a new approach to immunotherapy for a range of cancer and immune diseases. Its lead product candidate is soquelitinib, a selective, covalent inhibitor of ITK (interleukin 2 inducible T cell kinase) and is in a multi-center Phase 1/1b clinical trial in patients with various recurrent, malignant T cell lymphomas. Soquelitinib is designed to inhibit the proliferation of certain malignant T cells. Its second product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine designed to disable a tumor’s ability to subvert attack by the immune system by blocking the binding of immunosuppressive adenosine in the tumor microenvironment to the A2A receptor. The Company’s third product candidate is mupadolimab, a humanized monoclonal antibody that is designed to react with a specific site on CD73.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $129.5M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 62.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.12 |
EPS | $-0.51 |
Book Value | $0.79 |
P/E Ratio | -4.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.